Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
P M Ridker
Dr P M Ridker, Brigham and Women’s Hospital, Boston, MA, USA; firstname.lastname@example.org
randomised placebo-controlled trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin [JUPITER]). ClinicalTrials.gov NCT00239681.
blinded (patients, clinicians, data collectors, and outcome adjudication committee).*
1315 sites in 26 countries.
17 802 men ⩾50 years of age or women ⩾60 years of age (mean age 66 y, 62% men) who had no history of cardiovascular (CV) disease, high-sensitivity C-reactive protein concentrations ⩾2.0 mg/l, low-density lipoprotein cholesterol levels <3.4 mmol/l (130 mg/dl), and triglyceride concentrations <5.6 mmol/l (500 mg/dl). …
Source of funding: AstraZeneca.